Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.32.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
HS.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
KP.4.2.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
HK.1.2SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
EG.5.1.11SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
EG.5.1.12SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
HF.1.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
HK.22SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
CM.8.1.2SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
JN.1.48.2SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
LF.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
EG.5.1.16SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
JN.1.16.3SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
KB.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
JN.1.42SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
KR.4SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
MB.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
JD.1.1.5SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
LE.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
FL.15.1.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
JN.1.18.7SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
XBB.1.16.11SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
HV.1.6SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
BA.2.7SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
N.9SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
P.2 (Zeta)SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
BA.1.21SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
BN.1.3.6SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
XBB.1.5.25SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
CM.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-630.996US
BF.25NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-630.996US
BF.7.4.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-630.996US
BQ.1.1.43NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-630.996US
BM.1.1.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-630.996US
BF.28NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-630.996US
BG.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-630.996US
AE.8ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-643.025Germany
B.1.1.516ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-643.025Germany
B.1.1.526ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-643.025Germany
B.1.1.515ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-643.025Germany
B.1.287ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-643.025Germany
FN.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-643.025Germany
BA.4.6.5ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-643.025Germany
BF.7.6ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-643.025Germany
BA.5.2.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-643.025Germany
BQ.1.1.8ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-643.025Germany
BQ.1.1.66ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-643.025Germany
BA.4.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-643.025Germany
CM.4NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-675.04Hong Kong
FL.20NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-713.74US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used